Search results for “Cancer”

Precision Medicine in Action: Why Testicular Cancer Awareness Month Matters 

Apr 6, 2026

April is Testicular Cancer Awareness Month. This is an opportunity not only to emphasize early detection, but to reflect on how far oncology has advanced in the era of precision medicine. Testicular cancer represents one of the most curable solid tumors in modern oncology. Yet its management illustrates a broader truth: outcomes improve when early clinical vigilance is…

Read more →

March is Colorectal Cancer Awareness Month:

Mar 24, 2026

How VarSeq Helps Explore the Therapeutic Landscape for CRC Patients Colorectal Cancer Awareness Month for CRC Patients In honor of Colorectal Cancer Awareness Month, we’re taking a close look at how VarSeq’s VSClinical AMP workflow and evidence from Genomenon and Golden Helix CancerKB  can expose the right treatment strategies for…

Read more →

March Is Colorectal Cancer Awareness Month: Expanding Discovery Through Better Data and Better Analysis

Mar 5, 2026

March is Colorectal Cancer Awareness Month, a time to emphasize prevention through screening while also acknowledging how advances in genomics are reshaping how we understand, detect, and treat colorectal cancer. While colonoscopy remains the cornerstone of prevention, colorectal cancer continues to be one of the most common and deadly cancers…

Read more →

Comprehensive Cancer Variant Analysis in VarSeq

Feb 20, 2026

From Targeted Panels to Long-Read Genomes – Webcast Recap Thank you to everyone who joined our recent webcast, “Comprehensive Cancer Variant Analysis in VarSeq: From Targeted Panels to Long Read Genomes,” presented by Darby Kammeraad and Julia Love on February 18th, 2026. For those who missed it or need a…

Read more →

Seeing the Unseen: Reporting on Cancer Fusions with Long-Read Sequencing and Genomenon CKB

Feb 10, 2026

February is recognized as Cancer Prevention Month, with World Cancer Day on February 4 serving as a global reminder that improving outcomes in cancer depends on earlier detection, better diagnostics, and faster translation of data into clinical decisions. In precision oncology, early detection no longer stops at identifying the presence…

Read more →

February is Cancer Prevention Month

Feb 5, 2026

February is Cancer Prevention Month, a timely reminder that the most effective cancer intervention often happens long before a diagnosis is ever made. For decades, prevention has focused on lifestyle guidance and population-level screening. While important, these approaches overlook a critical reality: cancer risk is highly individualized. Genetics, molecular biology,…

Read more →

Reducing Cervical Cancer NGS Turnaround Time with VarSeq

Jan 20, 2026

When it comes to cervical cancer, early detection and timely analysis can literally be life-saving. Cervical cancer is the fourth most common cancer in women worldwide, with an estimated 660,000 new cases and around 350,000 deaths each year. Early detection through screening and quick diagnostic support drastically improves outcomes because,…

Read more →

Diffuse Midline Glioma Research is Evolving and CancerKB Evolves with It

Jan 13, 2026

Diffuse midline glioma (DMG) is one of the most urgent unmet needs in neuro-oncology. This rare, aggressive brain cancer primarily affects children and arises in critical midline structures of the brain, such as the brainstem and thalamus, where surgery is not feasible, and treatment options are severely limited. Its diffuse…

Read more →

Integrating Genomenon Cancer Knowledgebase (CKB) into VarSeq and VSClinical

Nov 19, 2025

Golden Helix’s VSClinical AMP guidelines platform, powered by our Golden Helix CancerKB has long been trusted by clinicians and researchers for generating report-ready clinical cancer biomarker interpretations. To further elevate the coverage and currency of our somatic variant evaluation capabilities, we’ve integrated Genomenon’s Cancer Knowledgebase (CKB) into both VarSeq and…

Read more →

Stop Hunting for Clinical Evidence: Let Golden Helix CancerKB Do the Work

Nov 11, 2025

Precision oncology moves fast, and labs need tools that can keep up. Golden Helix CancerKB is built for clinical labs that want high-quality, report-ready cancer interpretations without the manual workload or inconsistencies that slow teams down. Stay in the Loop with Golden Helix CancerKB Oncology doesn’t stand still and neither…

Read more →

November Webcast: Simplifying Complex Cancer Data into Actionable Knowledge

Nov 6, 2025

As precision oncology evolves, clinicians and laboratories need tools that can both handle massive genomic datasets and translate those findings into clear, clinically actionable guidance. In our recent webcast, “Simplifying Complex Cancer Data into Actionable Knowledge with Golden Helix CancerKB,” we walked through how Golden Helix CancerKB can take clinical…

Read more →

From Rare Disease to Cancer and Neurodegeneration: Customer Publications | September 2025

Sep 18, 2025

In recent years, the adoption of advanced bioinformatics platforms has enabled clinicians and researchers to identify novel variants, characterize complex inheritance patterns, and better understand the clinical impact of genetic disorders. Below are publications from customers in September 2025, showcasing the work built upon the trusted capabilities of our VarSeq…

Read more →

August 2025 Customer Publications: Applications in Cancer, Prenatal Testing & Rare Disease

Aug 26, 2025

At Golden Helix, we get to see firsthand how our software enables groundbreaking research around the world. Our tools are central to real-world discoveries, from cancer studies and prenatal diagnostics to uncovering new genetic links in rare diseases. These publications from August 2025 showcase how VarSeq and VSPipeline are helping…

Read more →

Enhancing Solid Tumor Analysis with Golden Helix CancerKB

Jul 15, 2025

This year, the Golden Helix CancerKB curation team has been hard at work expanding and refining the content that supports cancer variant interpretation and clinical reporting. In addition to staying current with the latest FDA-approved therapies and NCCN Guideline-recommended treatments, the team has taken on a significant new initiative: developing…

Read more →

June 2025 Customer Publications: Variant Classifications for Cancer & HHT

Jun 27, 2025

This month, our team at Golden Helix is proud to highlight a series of standout customer publications demonstrating the real-world impact of next-generation sequencing and variant analysis. Featured articles from June 2025 showcase the power of the VarSeq platform in supporting high-quality research across hereditary and somatic disease. From integrating…

Read more →

Golden Helix CancerKB 4.0 is Officially Released!

Nov 19, 2024

Just in time for the holidays, Golden Helix CancerKB 4.0 is now available to incorporate into your cancer analysis workflows! We have termed this release “The Hematological release” as we boast of complete coverage of the NCCN Guidelines recommended therapies and FDA-approved therapies for all hematological cancers in our Drug…

Read more →

How VarSeq Powers Research in Inherited Diseases and Cancer

Sep 25, 2024

Exome and genome sequencing have advanced genetic research, but data analysis remains complex. VarSeq simplifies this by helping researchers identify key genetic changes in rare diseases and cancer, improving screening and diagnosis. Here are recent customer publications that highlight VarSeq usage. Expanded carrier screening for inherited genetic disease using exome…

Read more →

Golden Helix CancerKB’s Focus on Hematological Cancer Interpretations

Sep 6, 2024

You might have noticed an uptick in the number of interpretations associated with hematological cancers within the Golden Helix CancerKB database over the past several months. This is because the Golden Helix CancerKB curation team has been focused on bolstering our drug sensitivity, diagnostic, and prognostic interpretations. This project has…

Read more →

A Hidden Gem Inside Golden Helix CancerKB

Jul 18, 2024

The FDA approved the first medical therapy for desmoid tumors only a few months ago! What’s the big deal, right? Desmoid tumors are non-cancerous and can’t even metastasize. Well, in this blog post, I want to discuss these interesting tumors, and you will find that not only are these tumors…

Read more →

Exploring VarSeq 2.5.0: Innovations in Somatic Analysis and Cancer Research

Dec 5, 2023

Thank you to all our viewers who attended our webcast last week on VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective. Overall, this webcast highlighted the versatility of VarSeq, demonstrating both a Tumor-Normal somatic workflow and a singleton somatic analysis. In addition, we got to see the utility of…

Read more →